ReviewOncoTargets and therapy2017
Amatuximab and novel agents targeting mesothelin for solid tumors.
Paolo Baldo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papertrialcites it
ReviewOncoTargets and therapy2017
Paolo Baldo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.